Arvee Laboratories [ARVEE] vs Tanfac Industries [TANFACIND] Detailed Stock Comparison

Arvee Laboratories
NSE
Loading...

Tanfac Industries
BSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Arvee Laboratories wins in 7 metrics, Tanfac Industries wins in 11 metrics, with 0 ties. Tanfac Industries appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Arvee Laboratories | Tanfac Industries | Better |
---|---|---|---|
P/E Ratio (TTM) | 85.55 | 48.54 | Tanfac Industries |
Price-to-Book Ratio | 6.25 | 14.95 | Arvee Laboratories |
Debt-to-Equity Ratio | 3.31 | 13.28 | Arvee Laboratories |
PEG Ratio | -2.35 | 0.68 | Arvee Laboratories |
EV/EBITDA | 54.04 | 36.16 | Tanfac Industries |
Profit Margin (TTM) | 3.88% | 15.83% | Tanfac Industries |
Operating Margin (TTM) | 2.84% | 18.58% | Tanfac Industries |
EBITDA Margin (TTM) | 2.84% | 18.58% | Tanfac Industries |
Return on Equity | 3.61% | 32.50% | Tanfac Industries |
Return on Assets (TTM) | 2.75% | 20.35% | Tanfac Industries |
Free Cash Flow (TTM) | $10.78M | $-641.87M | Arvee Laboratories |
Dividend Yield | N/A | 0.20% | N/A |
1-Year Return | -11.74% | 118.40% | Tanfac Industries |
Price-to-Sales Ratio (TTM) | 5.27 | 8.37 | Arvee Laboratories |
Enterprise Value | $1.86B | $46.60B | Tanfac Industries |
EV/Revenue Ratio | 6.12 | 8.37 | Arvee Laboratories |
Gross Profit Margin (TTM) | 41.17% | 38.17% | Arvee Laboratories |
Revenue per Share (TTM) | $32 | $558 | Tanfac Industries |
Earnings per Share (Diluted) | $1.98 | $96.29 | Tanfac Industries |
Beta (Stock Volatility) | N/A | -0.21 | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Arvee Laboratories vs Tanfac Industries Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Arvee Laboratories | -2.95% | 0.15% | -10.06% | 14.54% | 21.71% | -3.79% |
Tanfac Industries | -4.13% | 14.37% | 1.73% | 42.87% | 38.82% | 52.67% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Arvee Laboratories | -11.74% | 99.28% | 720.29% | 178.14% | 178.14% | 178.14% |
Tanfac Industries | 118.40% | 799.87% | 2,165.80% | 10,439.68% | 16,866.79% | 6,577.64% |
Performance & Financial Health Analysis: Arvee Laboratories vs Tanfac Industries
Metric | ARVEE | TANFACIND |
---|---|---|
Market Information | ||
Market Cap | ₹1.87B | ₹46.63B |
Market Cap Category | Small cap | Small cap |
10 Day Avg. Volume | 243 | 9,296 |
90 Day Avg. Volume | 893 | 17,249 |
Last Close | ₹164.40 | ₹4,481.10 |
52 Week Range | ₹126.54 - ₹235.79 | ₹1,890.00 - ₹4,961.40 |
% from 52W High | -30.28% | -9.68% |
All-Time High | ₹315.00 (Apr 08, 2024) | ₹4,961.40 (Jul 17, 2025) |
% from All-Time High | -47.81% | -9.68% |
Growth Metrics | ||
Quarterly Revenue Growth | -0.28% | 0.67% |
Quarterly Earnings Growth | -0.82% | 0.80% |
Financial Health | ||
Profit Margin (TTM) | 0.04% | 0.16% |
Operating Margin (TTM) | 0.03% | 0.19% |
Return on Equity (TTM) | 0.04% | 0.33% |
Debt to Equity (MRQ) | 3.31 | 13.28 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | ₹27.11 | ₹312.69 |
Cash per Share (MRQ) | N/A | ₹44.96 |
Operating Cash Flow (TTM) | ₹46.04M | ₹328.42M |
Levered Free Cash Flow (TTM) | ₹10.52M | ₹-860,044,864 |
Dividends | ||
Last 12-Month Dividend Yield | N/A | 0.20% |
Last 12-Month Dividend | N/A | ₹7.00 |
Valuation & Enterprise Metrics Analysis: Arvee Laboratories vs Tanfac Industries
Metric | ARVEE | TANFACIND |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 85.55 | 48.54 |
Forward P/E | N/A | N/A |
PEG Ratio | -2.35 | 0.68 |
Price to Sales (TTM) | 5.27 | 8.37 |
Price to Book (MRQ) | 6.25 | 14.95 |
Market Capitalization | ||
Market Capitalization | ₹1.87B | ₹46.63B |
Enterprise Value | ₹1.86B | ₹46.60B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 6.12 | 8.37 |
Enterprise to EBITDA | 54.04 | 36.16 |
Risk & Other Metrics | ||
Beta | N/A | -0.21 |
Book Value per Share (MRQ) | ₹27.11 | ₹312.69 |
Financial Statements Comparison: Arvee Laboratories vs Tanfac Industries
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | ARVEE | TANFACIND |
---|---|---|
Revenue/Sales | ₹89.09M | ₹1.72B |
Cost of Goods Sold | ₹52.41M | ₹997.76M |
Gross Profit | ₹36.68M | ₹721.74M |
Research & Development | N/A | N/A |
Operating Income (EBIT) | ₹729,000 | ₹319.53M |
EBITDA | ₹5.35M | ₹364.73M |
Pre-Tax Income | ₹2.07M | ₹311.96M |
Income Tax | ₹520,000 | ₹84.58M |
Net Income (Profit) | ₹1.55M | ₹227.38M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | ARVEE | TANFACIND |
---|---|---|
Cash & Equivalents | ₹3.58M | ₹301.18M |
Total Current Assets | ₹240.26M | ₹2.46B |
Total Current Liabilities | ₹68.79M | ₹1.08B |
Long-Term Debt | ₹10.00M | N/A |
Total Shareholders Equity | ₹310.38M | ₹3.12B |
Retained Earnings | N/A | N/A |
Property, Plant & Equipment | ₹129.87M | ₹1.68B |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | ARVEE | TANFACIND |
---|---|---|
Operating Cash Flow | N/A | N/A |
Capital Expenditures | N/A | N/A |
Free Cash Flow | N/A | N/A |
Debt Repayment | N/A | N/A |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | ARVEE | TANFACIND |
---|---|---|
Shares Short | N/A | N/A |
Short Ratio | N/A | N/A |
Short % of Float | N/A | N/A |
Average Daily Volume (10 Day) | 243 | 9,296 |
Average Daily Volume (90 Day) | 893 | 17,249 |
Shares Outstanding | 11.02M | 9.98M |
Float Shares | 2.31M | 3.57M |
% Held by Insiders | N/A | 0.75% |
% Held by Institutions | N/A | 0.00% |
Dividend Analysis & Yield Comparison: Arvee Laboratories vs Tanfac Industries
Metric | ARVEE | TANFACIND |
---|---|---|
Last 12-Month Dividend | N/A | ₹7.00 |
Last 12-Month Dividend Yield | N/A | 0.20% |
3-Year Avg Annual Dividend | N/A | ₹6.33 |
3-Year Avg Dividend Yield | N/A | 0.47% |
3-Year Total Dividends | N/A | ₹19.00 |
Ex-Dividend Date | N/A | Sep 20, 2024 |